Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity

Journal of Oral Pathology and Medicine

Volumn 44, Issue 1, 2015, Pages 15-27

  Zhang, Zhihui ^a   Han, Ying ^a   Song, Jiangyuan ^a   Luo, Ruxi ^a   Jin, Xin ^a   Mu, Dongdong ^a   Su, Sha ^a   Ji, Xiaoli ^a   Ren, Yan Fang ^b   Liu, Hongwei ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Indoleamine 2,3 dioxygenase; Interferon ; Mesenchymal stem cells; Oral lichen planus

Indexed keywords

CD34 ANTIGEN; CELL MARKER; ENDOGLIN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; PROTEIN STRO 1; THY 1 ANTIGEN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; STRO-1 ANTIGEN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CELL COUNTING; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LICHEN PLANUS; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; MOUTH MUCOSA; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGED; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; COCULTURE; CYTOLOGY; ENZYMOLOGY; IMMUNOLOGY; MESENCHYMAL STROMA CELL; MIDDLE AGED; MULTIPOTENT STEM CELL; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, SURFACE; ANTIGENS, THY-1; APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SELF RENEWAL; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HUMANS; IMMUNOMODULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; LICHEN PLANUS, ORAL; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MOUTH MUCOSA; MULTIPOTENT STEM CELLS; PHENOTYPE; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 84920268596     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12224     Document Type: Article

References (59)

1. Scully C, Beyli M, Ferreiro MC, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998; 9: 86-122.
2. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001; 59: 174-7.
3. Morhenn VB, Wood GS. Gamma interferon-induced expression of class II major histocompatibility complex antigens by human keratinocytes. Effects of conditions of culture. Ann N Y Acad Sci 1988; 548: 321-30.
4. Albanesi C, Cavani A, Girolomoni G. Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J Invest Dermatol 1998; 110: 138-42.
5. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 40-51.
6. Beltrami AP, Cesselli D, Bergamin N, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 2007; 110: 3438-46.
7. Kang HM, Kim J, Park S, et al. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells 2009; 27: 1999-2008.
8. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 2009; 88: 792-806.
9. Ivanovski S, Gronthos S, Shi S, et al. Stem cells in the periodontal ligament. Oral Dis 2006; 12: 358-63.
10. Alongi DJ, Yamaza T, Song Y, et al. Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential. Regen Med 2010; 5: 617-31.
11. Liu D, Xu J, Liu O, et al. Mesenchymal stem cells derived from inflamed periodontal ligaments exhibit impaired immunomodulation. J Clin Periodontol 2012; 39: 1174-82.
12. Liu D, Xu J, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25: 2896-902.
13. Tomar GB, Srivastava RK, Gupta N, et al. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 2010; 393: 377-83.
14. Chen M, Su W, Lin X, et al. Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum 2013; 65: 1181-93.
15. Marynka-Kalmani K, Treves S, Yafee M, et al. The lamina propria of adult human oral mucosa harbors a novel stem cell population. Stem Cells 2010; 28: 984-95.
16. Davies LC, Locke M, Webb RD, et al. A multipotent neural crest-derived progenitor cell population is resident within the oral mucosa lamina propria. Stem Cells Dev 2010; 19: 819-30.
17. Zhang QZ, Nguyen AL, Yu WH, et al. Human oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells. J Dent Res 2012; 91: 1011-18.
18. Fox JM, Chamberlain G, Ashton BA, et al. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007; 137: 491-502.
19. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
20. Leal A, Ichim TE, Marleau AM, et al. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease. Cell Immunol 2008; 253: 11-15.
21. Zhang Q, Shi S, Liu Y, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 2009; 183: 7787-98.
22. Jones BJ, Brooke G, Atkinson K, et al. Immunosuppression by placental indoleamine 2, 3-dioxygenase: a role for mesenchymal stem cells. Placenta 2007; 28: 1174-81.
23. Lee RH, Oh JY, Choi H, et al. Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem 2011; 112: 3073-8.
24. Maher SG, Romero-Weaver AL, Scarzello AJ, et al. Interferon: cellular executioner or white knight? Curr Med Chem 2007; 14: 1279-89.
25. Curti A, Trabanelli S, Salvestrini V, et al. The role of indoleamine 2, 3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 2009; 113: 2394-401.
26. van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003; 32: 507-12.
27. Xiao E, Li JM, Yan YB, et al. Decreased osteogenesis in stromal cells from radiolucent zone of human TMJ ankylosis. J Dent Res 2013; 92: 450-5.
28. Tang L, Li N, Xie H, et al. Characterization of mesenchymal stem cells from human normal and hyperplastic gingiva. J Cell Physiol 2011; 226: 832-42.
29. Yu J, Ren X, Cao S, et al. Beneficial effects of fetal-maternal microchimerism on the activated haplo-identical peripheral blood stem cell treatment for cancer. Cytotherapy 2008; 10: 331-9.
30. Gregory CA, Gunn WG, Peister A, et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004; 329: 77-84.
31. Kim WK, Jung H, Kim DH, et al. Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes. J Cell Sci 2009; 122: 4160-7.
32. Pacary E, Legros H, Valable S, et al. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J Cell Sci 2006; 119: 2667-78.
33. Munn DH, Mellor AL. Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007; 117: 1147-54.
34. Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2, 3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 2005; 106: 2375-81.
35. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by kynurenines. Adv Exp Med Biol 2003; 527: 183-90.
36. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78: 55-62.
37. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003; 116: 1827-35.
38. Stewart K, Monk P, Walsh S, et al. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res 2003; 313: 281-90.
39. Zannettino AC, Paton S, Kortesidis A, et al. Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1 bright/CD34/CD45(-)/glycophorin-A-bone marrow cells. Haematologica 2007; 92: 1707-8.
40. Eleuterio E, Trubiani O, Sulpizio M, et al. Proteome of human stem cells from periodontal ligament and dental pulp. PLoS ONE 2013; 8: e71101.
41. Barry FP, Boynton RE, Haynesworth S, et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999; 265: 134-9.
42. Aslan H, Zilberman Y, Kandel L, et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 2006; 24: 1728-37.
43. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-4.
44. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
45. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403.
46. Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 2000; 97: 13625-30.
47. Szpaderska AM, Zuckerman JD, Dipietro LA. Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 2003; 82: 621-6.
48. English K, Mahon BP. Allogeneic mesenchymal stem cells: agents of immune modulation. J Cell Biochem 2011; 112: 1963-8.
49. Prockop DJ, Oh JYMesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 2012; 20: 14-20.
50. Pilli M, Penna A, Zerbini A, et al. Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology 2002; 36: 1446-52.
51. MacKenzie CR, Langen R, Takikawa O, et al. Inhibition of indoleamine 2, 3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis. Eur J Immunol 1999; 29: 3254-61.
52. Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389-97.
53. Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2009; 3: 269-91.
54. Curti A, Pandolfi S, Valzasina B. et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 2007; 109: 2871-7.
55. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003; 24: 242-248.
56. Croitoru-Lamoury J, Lamoury FM, Caristo M, et al. Interferon-gamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2, 3 dioxygenase (IDO). PLoS ONE 2011; 6: e14698.
57. Ben-Hur T, Ben-Menachem O, Furer V, et al. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 2003; 24: 623-31.
58. Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med 2011; 17: 1594-601.
59. Su WR, Zhang QZ, Shi SH, et al. Human gingiva-derived mesenchymal stromal cells attenuate contact hypersensitivity via prostaglandin E2-dependent mechanisms. Stem Cells 2011; 29: 1849-60.